Clinical Trials Directory

Trials / Completed

CompletedNCT00664937

Exercise Induced Bronchoconstriction (0476-359)

A 3 Period, Double-Blind, Randomized Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo on Exercise-Induced Bronchoconstriction as Assessed by Hyperpolarized Gas Magnetic Resonance Imaging.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Organon and Co · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Exercise-induced bronchoconstriction (EIB) is a condition where airways tighten when you exercise and may cause coughing, wheezing, or shortness of breath. In many patients, this condition can cause lung function to drop making it harder to breath. An instrument called a spirometer is commonly used to measure lung function. This traditional means of assessing lung function in asthma is limited in its ability to provide information as to where in the lung the tightness is. Hyperpolarized helium magnetic resonance imaging (3He MRI) is a novel way to see the where air is going in the lungs using an MRI and special gas. The ability to see where the air can and cannot reach in the lungs may help show more accurately if a medication is working to make the asthma better. The purpose of this study is to examine patients with EIB in order to see if 3He MRI provides a better way to measure lung function. Patients will be given either montelukast sodium, a drug to improve the ability to breath with EIB, or placebo and then put on a treadmill to induce an occurrence of airway constriction. The patient's lung function will be measured more than once using both the spirometer and the 3He MRI.

Conditions

Interventions

TypeNameDescription
DRUGmontelukast sodiumsingle oral dose, before exercise challenge, of montelukast 10mg; 7 week duration.
DRUGComparator: placebo (unspecified)single oral dose, before exercise challenge, of Pbo; 7 week duration.

Timeline

Start date
2007-05-01
Primary completion
2008-10-01
Completion
2008-10-01
First posted
2008-04-23
Last updated
2024-05-09

Source: ClinicalTrials.gov record NCT00664937. Inclusion in this directory is not an endorsement.